ILID
LIVE

Serial Number

79436977

Owner

Ostomycure AS

Attorney

Michael Justus

Filing Date

Sep 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ILID Trademark

Serial Number: 79436977

ILID is a trademark filed by Ostomycure AS on September 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ostomycure AS (4 trademarks)

Gaustadalleen 21
Oslo N-0349 , NO

Entity Type: 03

Trademark Details

Filing Date

September 9, 2025

Registration Date

Not Registered

Published for Opposition

September 15, 2026

Goods & Services

Medical services; providing medical information; medical consultancy and medical information for patients, doctors and other healthcare and nursing professionals in connection with ostomy care; medical consultancy and medical information for patients, doctors and other healthcare professionals in connection with ostomy care, the irrigation of continent and incontinent reservoirs in the body, and the implantation of percutaneous implants; medical consultancy and medical information for patients, doctors and other healthcare professionals relating to the treatment of inflammatory bowel diseases, Crohn's disease, ulcerative colitis and cancer; none of the aforementioned services are related to eyelids and skin.

Pharmaceutical and medical preparations for the treatment of inflammatory bowel diseases, Crohn's disease, ulcerative colitis and cancer and veterinary preparations for small animals for gastrointestinal conditions; sanitary preparations for medical purposes; dietary food and beverages adapted for medical use; plasters for medical purposes, materials for dressings in the nature of sterilized dressings, bandages for dressings, wadding for dressings; disinfectants; medicated compresses; medical dressings; germicides; wound dressings; medicinal preparations and substances, namely, medicinal preparations for treatment of inflammatory bowel diseases, Crohn's disease, ulcerative colitis and cancer; pharmaceutical preparations for the cleaning of stomas; none of the aforementioned products are cleaning, hygiene products or medicated protective creams for eyelids and skin

Surgical apparatus and instruments for use in ileostomy surgery; suture materials; stoma protectors, namely, medical devices for closing wounds, wound drainage apparatus; ostomy bags; ostomy seals being ostomy flanges used with pouching systems; ostomy instruments, namely, ostomy pouches and ostomy flanges used with pouching systems; medical aids for use in stoma care, namely, ostomy pouches and ostomy flanges used with pouching systems; ostomy implants comprised of natural, non-living materials; medical irrigation apparatus for continent and incontinent ostomy patients; covers and plugs for the temporary sealing of ostomy patches and ostomy implants being medical devices for closing wounds; component parts and accessories for the foregoing.

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 9, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 18, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 18, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 18, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 18, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 10, 2026 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Apr 9, 2026 LIMG
REFUSAL PROCESSED BY IB
Mar 12, 2026 RFNT
LIMITATION OF GOODS RECEIVED FROM IB
Mar 12, 2026 LIMG
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 18, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 18, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 13, 2025 REPR